CVS Health
CVS
1,549 hedge funds and large institutions have $68.7B invested in CVS Health in 2016 Q4 according to their latest regulatory filings, with 170 funds opening new positions, 546 increasing their positions, 747 reducing their positions, and 164 closing their positions.
4% more first-time investments, than exits
New positions opened: 170 | Existing positions closed: 164
1% less funds holding
Funds holding: 1,564 → 1,549 (-15)
0.97% less ownership
Funds ownership: 82.51% → 81.54% (-0.97%)
11% less capital invested
Capital invested by funds: $77.3B → $68.7B (-$8.67B)
13% less call options, than puts
Call options by funds: $774M | Put options by funds: $884M
27% less repeat investments, than reductions
Existing positions increased: 546 | Existing positions reduced: 747
39% less funds holding in top 10
Funds holding in top 10: 136 → 83 (-53)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$743M |
| 2 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
+$432M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$339M |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$292M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$233M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$955M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$555M |
| 3 |
Morgan Stanley
New York
|
-$474M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$406M |
| 5 |
D.E. Shaw & Co
New York
|
-$391M |
CVS Hedge Fund Activity: Q4 2016 in Review
1,549 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2016, worth a combined $68.7B — down 11% from $77.3B a quarter earlier.
Buyers outnumbered sellers: 170 funds opened new CVS positions and 164 closed out — a net gain of 6 holders — while 546 added to existing stakes and 747 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $743M. The largest seller was Fidelity Investments, cutting an estimated $955M.
- 1,549 institutional investors held CVS Health (CVS) as of Q4 2016, down from 1,564 in Q3 2016.
- Funds reported $68.7B of CVS Health stock for Q4 2016, down 11% quarter-over-quarter.
- 170 funds opened new CVS Health positions in Q4 2016 and 164 closed out, a net change of +6 holders.
- The largest CVS Health buyer in Q4 2016 was Barrow, Hanley, Mewhinney & Strauss, an estimated $743M added.
- The largest CVS Health seller in Q4 2016 was Fidelity Investments, an estimated $955M sold.
Based on aggregated 13F filings for Q4 2016.